How long can you live after stem cell transplant?

A stem cell transplant can help you live longer. In some cases, it can even cure cancers of the blood.

How long can you live after stem cell transplant?

A stem cell transplant can help you live longer. In some cases, it can even cure cancers of the blood. About 50, 000 transplants are performed annually, and the number increases by 10% to 20% every year. More than 20,000 people have lived five years or more after having a stem cell transplant.

It usually takes 3 to 12 months for the immune system to recover from the transplant. The first year after transplantation is like the first year of a newborn baby's life. During this time, you are at risk of contracting an infection. The transplant team will check your blood cell count to see how well your immune system is working.

Depending on your blood cell count, you may make changes or additions to the guidelines below. Registries covering a total of 4,329 patients were reviewed, with a median age at diagnosis of 59.Throughout the group, these individuals were followed for a median of 10.5 years and a median overall survival of 6.9 years. After three years of follow-up, almost 72% of patients had not progressed. The long-term survival of people with multiple myeloma after autologous stem cell transplantation has steadily improved since 1997 with the introduction of new drugs, a large review study reports.

An important component of multiple myeloma treatment is autologous stem cell transplantation (ASCT), which involves using the patient's own healthy blood stem cells to replace diseased or damaged bone marrow. You receive chemotherapy and sometimes radiation therapy to prepare your body to receive healthy cells from the donor. Risk reduction was most pronounced among patients who underwent a transplant when they were under 18 years of age and those who received bone marrow as a source of stem cells. Your bracelet or necklace must be engraved with the words “Autologous stem cell transplant” and “Only irradiated cellular blood components and blood components safe for CMV”.

Since its first application in 1957 among identical twins1, indications for allogeneic hematopoietic stem cell transplantation have evolved substantially. Researchers also identified a previously unreported association between peripheral blood stem cell use in BMT and overall mortality risk, as well as infection-related mortality risk and lung mortality. Bone marrow transplant, also called stem cell transplant, is a medical treatment that replaces bone marrow with healthy cells. Hematopoietic cell transplantation (HCT) has been used for more than 40 years to treat hematologic malignancies and non-malignant diseases that could not be cured with other therapies.

The study, “Long-Term Outcomes After Autologous Stem Cell Transplantation for Multiple Myeloma,” was published in the journal Blood Advances. When you have an ALLO transplant, your doctor will give you chemotherapy, with or without radiation therapy or other medications, to prevent the body's immune system from destroying new cells.